You're reading the free version. Trader adds the live tape and alerts.
Start tracking
KNSA Exercise Disclosure
Quart Barry D · SEC Form 4 · Filed Jun 2, 2026
Exercise
Reported value range
Not reported
Quart Barry D Director
KNSA
Transaction date
May 29, 2026
Public filing date
Jun 2, 2026
Filing lag
Filed 4 days later
KNSA daily price context
Close on/before transaction
$48.38
May 29, 2026
First close after public filing
$47.85
Jun 3, 2026
30-day return after filing
+34.86%
Through Jul 2, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Class A Ordinary Share
- Quantity / price
- 2,799 shares
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001384243-26-000012
Filing cohort
Transactions in this filing
Showing 4 of 4
Trades
4
Issuers
1
Estimated value
$0
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Kiniksa Pharmaceuticals International, Plc KNSA Current | Exercise | May 29, 2026 | Not reported |
| Kiniksa Pharmaceuticals International, Plc KNSA | Award | May 29, 2026 | $0 |
| Kiniksa Pharmaceuticals International, Plc KNSA | Award | May 29, 2026 | $0 |
| Kiniksa Pharmaceuticals International, Plc KNSA | Exercise | May 29, 2026 | $0 |